RPID - Rapid Micro Biosystems Inc

RPID - Rapid Micro Biosystems Inc

https://www.rapidmicrobio.com

Recent News

Powered by Alpha Vantage

Rapid Micro Biosystems to Present at the H.C. Wainwright 27th Annual Global Investment Conference - Rapid Micro Biosystems ( NASDAQ:RPID )

Benzinga • 1 week, 5 days ago • score: 0.51

LEXINGTON, Mass., Sept. 02, 2025 ( GLOBE NEWSWIRE ) -- Rapid Micro Biosystems, Inc.

Rapid Micro Biosystems to Present at the H.C. Wainwright 27th Annual Global Investment Conference

GlobeNewswire • 1 week, 5 days ago • score: 0.54

LEXINGTON, Mass., Sept. 02, 2025 ( GLOBE NEWSWIRE ) -- Rapid Micro Biosystems, Inc. ( Nasdaq: RPID ) ( the "Company" ) , an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare ...

Rapid Micro Biosystems, Inc. ( RPID ) Reports Q2 Loss, Misses Revenue Estimates

Zacks Commentary • 1 month ago • score: 0.11

Rapid Micro Biosystems (RPID) delivered earnings and revenue surprises of -3.85% and -0.52%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Rapid Micro Biosystems to Announce Second Quarter 2025 Financial Results on August 12, 2025 - Rapid Micro Biosystems ( NASDAQ:RPID )

Benzinga • 1 month, 2 weeks ago • score: 0.46

LEXINGTON, Mass., July 31, 2025 ( GLOBE NEWSWIRE ) -- Rapid Micro Biosystems, Inc.

Rapid Micro Biosystems to Announce Second Quarter 2025 Financial Results on August 12, 2025

GlobeNewswire • 1 month, 2 weeks ago • score: 0.53

LEXINGTON, Mass., July 31, 2025 ( GLOBE NEWSWIRE ) -- Rapid Micro Biosystems, Inc. ( Nasdaq: RPID ) ( the "Company" ) , an innovative life sciences technology company providing mission-critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare ...

Interval:

EMA1: EMA2:

AI Tools

Key Metrics

Trend: Downtrend

Source: Snapshot

None

52W High

$4.50

52W Low

$0.80

MA Status:

50D: Below 200D: Below

Beta (~1 neutral, <0.9 lower risk)

1.30

Valuation

As of 2025-06-30 (Overview)

Trailing P/E (<15 better)

N/A

Forward P/E (<15 better)

N/A

EV/EBITDA (<8 favorable)

0.83

EV/Revenue (<3 favorable)

3.12

P/S (TTM) (<3 favorable)

3.97

P/B (<3 favorable)

2.21

Ownership

Balanced

Source: Overview

Insiders (1–5% typical)

9.60%

Institutions (25–75% balanced)

59.55%

Shares Outstanding

39,710,800

Float

19,338,000

Dividend Yield (2–6% sweet spot)

N/A

Ex‑Dividend Date

N/A

Income & Growth

Profitability: Weak

As of 2025-06-30 (Overview)

Revenue (TTM)

30,289,000

Gross Profit (TTM)

2,282,000

EPS (TTM)

-1.00

Profit Margin (>10% good)

-1.46%

Operating Margin (TTM) (higher better)

-1.67%

ROE (TTM) (>15% strong)

-0.59%

EPS YoY (Quarterly) (>10% good)

N/A

Revenue YoY (Quarterly) (>8% good)

0.10

Momentum

Value

N/A

Previous

N/A

Trend

—

Signal Cross

No cross

As of

—